Valamehr Bahram

Insider Buys Quantity –
0
2024-01-09SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
11,271
0.0114%
$4.38$49,367+8.96%
2023-01-10SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
10,917
0.0106%
$5.24$57,205-13.57%
2022-07-07SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
17,158
0.0173%
$30.23$518,686-68.12%
2022-07-06SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
7,842
0.0085%
$30.07$235,809-65.07%
2022-03-14SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
2,960
0.0034%
$33.30$98,568-24.5%
2022-01-11SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
4,570
0.0048%
$48.50$221,655-43.63%
2022-01-10SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
5,596
0.0055%
$46.38$259,558-45.37%
2021-12-13SaleFate Therapeutics, Inc.
FATE
Chief R&D Officer
25,000
0.0257%
$47.66$1.19M-39.14%
2021-09-13SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
25,000
0.0264%
$66.29$1.66M-44.34%
2021-06-14SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
25,000
0.0263%
$89.32$2.23M-40.2%
2021-03-15SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
25,000
0.0266%
$92.35$2.31M-26.56%
2021-01-11SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
3,254
0.0034%
$110.81$360,588-31.03%
2021-01-08SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
6,230
0.0067%
$117.10$729,552-33.06%
2020-12-14SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
50,000
0.0581%
$97.78$4.89M-15.66%
2020-09-14SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
50,000
0.0558%
$36.31$1.82M+120.49%
2020-01-08SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
11,400
0.0141%
$20.69$235,895+51.02%
2019-10-15SaleFate Therapeutics, Inc.
FATE
Chief Development Officer
12,400
0.0158%
$14.18$175,781+95.66%
Stocks ScreenerTop-50 StocksInsiders ScreenerList of All Stocks
About Prismo.proPrivacy PolicyTerms of ServiceContact Us